Skip to main content

Table 3 Mean score of each area of ASQ for different ages in the case and control group

From: Growth and neurodevelopmental status in patients with retinopathy of prematurity treated with intravitreal bevacizumab: a case–control study

Area

Exam time point (corrected post-gestational age)

P value

(between two groups)

6 month

12 month

18 month

Communication

 Case

1.80 ± 0.17

1.68 ± 0.41

1.72 ± 0.34

0.168

 Control

1.55 ± 0.48

1.74 ± 0.36

1.58 ± 0.46

 P value

0.047

0.594

0.463

 

Gross motor

 Case

1.39 ± 0.46

1.55 ± 0.50

1.83 ± 0.39

0.122

 Control

1.46 ± 0.47

1.57 ± 0.66

1.94 ± 0.08

 P value

0.691

0.874

0.507

 

Fine motor

 Case

1.49 ± 0.52

1.79 ± 0.29

1.58 ± 0.31

0.275

 Control

1.69 ± 0.47

1.82 ± 0.28

1.68 ± 0.26

 P value

0.275

0.773

0.520

 

Problem solving

 Case

1.33 ± 0.38

1.72 ± 0.37

1.67 ± 0.31

0.469

 Control

1.55 ± 0.58

1.77 ± 0.39

1.80 ± 0.16

 P value

0.261

0.684

0.373

 

Social-personal

 Case

1.60 ± 0.45

1.58 ± 0.43

1.89 ± 0.08

0.627

 Control

1.65 ± 0.48

1.71 ± 0.51

1.83 ± 0.21

 P value

0.795

0.265

0.518

 

Overall

 Case

1.16 ± 0.34

1.03 ± 0.24

1.30 ± 0.28

0.512

 Control

1.09 ± 0.15

1.08 ± 0.26

1.20 ± 0.31

 P value

0.482

0.476

0.508